288 related articles for article (PubMed ID: 30456745)
21. Clinical presentation and patterns of slow transit constipation do not predict coexistent upper gut dysmotility.
Zarate N; Knowles CH; Yazaki E; Lunnis PJ; Scott SM
Dig Dis Sci; 2009 Jan; 54(1):122-31. PubMed ID: 18600457
[TBL] [Abstract][Full Text] [Related]
22. Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine.
Solismaa A; Kampman O; Lyytikäinen LP; Seppälä N; Viikki M; Mononen N; Lehtimäki T; Leinonen E
J Clin Psychopharmacol; 2018 Jun; 38(3):193-199. PubMed ID: 29620694
[TBL] [Abstract][Full Text] [Related]
23. Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis.
Kalaitzakis E; Sadik R; Holst JJ; Ohman L; Björnsson E
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):346-52. PubMed ID: 19200458
[TBL] [Abstract][Full Text] [Related]
24. Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility.
Dalziel JE; Young W; Bercik P; Spencer NJ; Ryan LJ; Dunstan KE; Lloyd-West CM; Gopal PK; Haggarty NW; Roy NC
Neurogastroenterol Motil; 2016 Aug; 28(8):1241-51. PubMed ID: 27028044
[TBL] [Abstract][Full Text] [Related]
25. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
[TBL] [Abstract][Full Text] [Related]
26. Associations Between Physical Activity and Gastrointestinal Transit Times in People with Normal Weight, Overweight, and Obesity.
Jensen MM; Pedersen HE; Clemmensen KKB; Ekblond TS; Ried-Larsen M; Færch K; Brock C; Quist JS
J Nutr; 2024 Jan; 154(1):41-48. PubMed ID: 37315794
[TBL] [Abstract][Full Text] [Related]
27. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
[TBL] [Abstract][Full Text] [Related]
28. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
[TBL] [Abstract][Full Text] [Related]
29. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.
Camilleri M; Brown ML; Malagelada JR
Gastroenterology; 1986 Sep; 91(3):619-26. PubMed ID: 3525315
[TBL] [Abstract][Full Text] [Related]
30. Prokinetic effects of mirtazapine on gastrointestinal transit.
Yin J; Song J; Lei Y; Xu X; Chen JD
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G796-801. PubMed ID: 24627566
[TBL] [Abstract][Full Text] [Related]
31. Severe gastroparesis is associated with an increased incidence of slow-transit constipation as measured by wireless motility capsule.
Radetic M; Kamal A; Rouphael C; Kou L; Lyu R; Cline M
Neurogastroenterol Motil; 2021 May; 33(5):e14045. PubMed ID: 33231369
[TBL] [Abstract][Full Text] [Related]
32. Early-life malnutrition causes gastrointestinal dysmotility that is sexually dimorphic.
Soni KG; Dike PN; Suh JH; Halder T; Edwards PT; Foong JPP; Conner ME; Preidis GA
Neurogastroenterol Motil; 2020 Dec; 32(12):e13936. PubMed ID: 33021011
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal symptoms and cardiac vagal tone in type 1 diabetes correlates with gut transit times and motility index.
Wegeberg AL; Brock C; Ejskjaer N; Karmisholt JS; Jakobsen PE; Drewes AM; Brock B; Farmer AD
Neurogastroenterol Motil; 2021 Jan; 33(1):e13885. PubMed ID: 32573076
[TBL] [Abstract][Full Text] [Related]
34. Effects of antipsychotics on intestinal motility in zebrafish larvae.
de Alvarenga KAF; Sacramento EK; Rosa DV; Souza BR; de Rezende VB; Romano-Silva MA
Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 27981679
[TBL] [Abstract][Full Text] [Related]
35. Effect of tegaserod on gut transit in male and female subjects.
Degen L; Petrig C; Studer D; Schroller S; Beglinger C
Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
[TBL] [Abstract][Full Text] [Related]
36. Relationship between impaired gastric emptying and abnormal gastrointestinal motility.
Camilleri M; Brown ML; Malagelada JR
Gastroenterology; 1986 Jul; 91(1):94-9. PubMed ID: 3710086
[TBL] [Abstract][Full Text] [Related]
37. Randomised study: effects of the 5-HT
Chedid V; Brandler J; Arndt K; Vijayvargiya P; Wang XJ; Burton D; Harmsen WS; Siegelman J; Chen C; Chen Y; Almansa C; Dukes G; Camilleri M
Aliment Pharmacol Ther; 2021 May; 53(9):1010-1020. PubMed ID: 33711180
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies.
Rao SS; Camilleri M; Hasler WL; Maurer AH; Parkman HP; Saad R; Scott MS; Simren M; Soffer E; Szarka L
Neurogastroenterol Motil; 2011 Jan; 23(1):8-23. PubMed ID: 21138500
[TBL] [Abstract][Full Text] [Related]
39. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans.
Bouras EP; Burton DD; Camilleri M; Stephens DA; Thomforde GM
Neurogastroenterol Motil; 2004 Dec; 16(6):729-35. PubMed ID: 15601422
[TBL] [Abstract][Full Text] [Related]
40. Effect of subtotal colectomy on gastric emptying of a solid meal in slow-transit constipation.
Mollen RM; Hopman WP; Oyen WJ; Kuijpers HH; Edelbroek MA; Jansen JB
Dis Colon Rectum; 2001 Aug; 44(8):1189-95. PubMed ID: 11535861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
